Clinical Trial Update: Efficacy and Safety of Oral Bosentan on Healing/Prevention of Digital (Finger) Ulcers in Patients With Scleroderma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of oral bosentan for healing and prevention of digital ulcers in patients with systemic sclerosis (scleroderma)…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Digital Ulcers
• Systemic Sclerosis

Drugs mentioned

• Bosentan (Bosentan)

Snippet

Sponsor: Actelion | Conditions: Digital Ulcers, Systemic Sclerosis | Phase 3 | Status: COMPLETED